Treatment Group

Serum E2 (pg/mL)a

Wet uterus weight (mg)a

Uterus E2 concentration (pg/g)a

Control

13 ± 3b

20 ± 2

545 ± 138

Day 1

874 ± 33*

70 ± 2*

1719 ± 73*

Day 2

351 ± 10*

91 ± 3*

2988 ± 492*

Day 4

150 ± 9*

64 ± 2*

3738 ± 591*

Day 8

48 ± 7*

32 ± 2*

683 ± 112

a Values are mean ± SEM; b Below assay LOQ; *Significant difference compared to control (ANOVA analysis followed by post hoc Dunnett test; p<0.05, n= 3–6)
Table 1: Serum E2 levels, wet uterus weights and E2 content in the uterus determined by LC-MS/MS [22]. OVX CD-1 mice received a single dose of E2-CDS (300 μg/kg body weight, i.v.) formulated as HPBCD inclusion complex (Estredox). The control group received vehicle only. After drug administration, animals were tested in PST at selected time points (1, 2, 4, and 8 days), then sacrificed; blood and tissues were collected and processed.